Tumor-infiltrating immune cells and pd-l1 as prognostic biomarkers in primary esophageal small cell carcinoma

HIGHLIGHTS

• who: Xiao Wu et al. from the Cancer Research Center, Shantou University Medical College, Shantou, Guangdong, China have published the Article: Tumor-Infiltrating Immune Cells and PD-L1 as Prognostic Biomarkers in Primary Esophageal Small Cell Carcinoma, in the Journal: Journal of Immunology Research 0 of 29/Dec/2020
• what: The authors aim to identify the TIME and provide indication for the applicability of immune checkpoint therapy in PESCC.
• how: When patients were categorized into a PD-L1-positive group and a PD-L1-negative group for the correlation between PD-L1 expression . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.